BnR Summit 2025

Belt and Road Summit 2025- Deal-making

10 – 16 Sept 2025 | China (Hong Kong)

ProjectUpdated on 3 September 2025

GUTolution AI-Driven Micrbiome Testing

Gabriel Chan

Head of Partnerships at GUTolution Limited

Hong Kong, China (Hong Kong)

About

GUTolution is a biotechnology company revolutionizing healthspan extension by addressing chronic illnesses with personalized microbiome health solutions. Specializing in at-home health tests, precision supplements, and microbiome medicine, we combine cutting-edge next-generation sequencing (NGS) with our patent-pending AI platform to deliver accurate and tailored interventions based on individual gut microbiomes. 

Backed by research partnerships with prestigious universities and business collaborations with listed healthcare companies, we’ve achieved rapid sales growth through B2C subscriptions and B2B partnerships, also strategically expanding into Southeast Asia and the Middle East—regions with rising demand for chronic illness solutions. Our team of young talents consists of PhD and experts in biotechnology, AI, and nutrition. Currently, we are seeking seed/Pre-A funding to accelerate our global expansion and revolutionize microbiome health worldwide.

Project Location

  • China (Hong Kong)

Project Format

  • Private Project

ESG (Environmental, Social, and Governance)

  • Yes

Project Stage

  • Project Planning

Main Project Sector

  • Technology

Technology

  • Bio-Tech
  • Health Technology
  • Medical Technology

Urban Development

  • Health Facilities

Total Project Value

  • 500,001 to 1,000,000 USD

Previous Funding Stage

  • Seed & Pre-Series

Main Service(s) Required

  • Professional Services

Information Technology Services

  • E-commerce

Professional Services

  • Business Valuation
  • IP Related

Organisation

GUTolution Limited

Hong Kong, China (Hong Kong)

Similar opportunities